全文获取类型
收费全文 | 7002篇 |
免费 | 339篇 |
国内免费 | 8篇 |
出版年
2023年 | 12篇 |
2021年 | 60篇 |
2020年 | 42篇 |
2019年 | 62篇 |
2018年 | 96篇 |
2017年 | 82篇 |
2016年 | 114篇 |
2015年 | 194篇 |
2014年 | 248篇 |
2013年 | 525篇 |
2012年 | 419篇 |
2011年 | 426篇 |
2010年 | 265篇 |
2009年 | 285篇 |
2008年 | 465篇 |
2007年 | 444篇 |
2006年 | 432篇 |
2005年 | 492篇 |
2004年 | 485篇 |
2003年 | 455篇 |
2002年 | 409篇 |
2001年 | 62篇 |
2000年 | 78篇 |
1999年 | 72篇 |
1998年 | 92篇 |
1997年 | 74篇 |
1996年 | 74篇 |
1995年 | 82篇 |
1994年 | 54篇 |
1993年 | 65篇 |
1992年 | 59篇 |
1991年 | 55篇 |
1990年 | 41篇 |
1989年 | 46篇 |
1988年 | 31篇 |
1987年 | 44篇 |
1986年 | 36篇 |
1985年 | 28篇 |
1984年 | 39篇 |
1983年 | 36篇 |
1982年 | 44篇 |
1981年 | 34篇 |
1980年 | 23篇 |
1979年 | 32篇 |
1978年 | 27篇 |
1977年 | 18篇 |
1976年 | 23篇 |
1975年 | 11篇 |
1974年 | 11篇 |
1973年 | 12篇 |
排序方式: 共有7349条查询结果,搜索用时 78 毫秒
991.
Takada M Shimomura T Hokari S Jensik PJ Cox TC 《Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology》2006,176(4):287-293
Amiloride-blockable Na+ transport, measured as an amiloride-blockable short-circuit current (Am-SCC), is mediated by the epithelial Na+ channel (ENaC). Am-SCC is not normally present in bullfrog tadpole skin, but when such skin is cultured with corticoids an
amiloride-blockable Na transport appears. Prolactin (PRL) inhibits its corticoid-induced development. Using specific PCR primers
for adult frog ENaC and RT-PCR, we investigated whether corticoids can induce all three ENaC subunits, and whether this expression
of ENaC subunit(s) can be blocked by adding PRL with the corticoids. We found that (1) the sequences of the RT-PCR products
obtained using primers for α-ENaC were identical between larval and adult skins, (2) the mRNAs for all three ENaC subunits
were expressed in larval skin under normal conditions despite no amiloride-blockable Na+ transport being detectable, (3) all three subunits were expressed in larval skins whether they were cultured with corticoids
(amiloride-blockable Na transport present) or with corticoids supplemented with PRL (no amiloride-blockable Na transport present).
An antibody against a peptide from the α-ENaC of adult bullfrog was localized to the apical cells of both larval and adult
skins. Since no amiloride-blockable Na transport exists across larval skin under these conditions, these results suggest that
ENaC protein was expressed prior to the onset of transport. ENaC may be in the plasma membrane in an inactivated form or,
alternatively, within vesicles waiting to be inserted. 相似文献
992.
993.
HACN (homoaconitase) is a member of a family of [4Fe-4S] cluster-dependent enzymes that catalyse hydration/dehydration reactions. The best characterized example of this family is the ubiquitous ACN (aconitase), which catalyses the dehydration of citrate to cis-aconitate, and the subsequent hydration of cis-aconitate to isocitrate. HACN is an enzyme from the alpha-aminoadipate pathway of lysine biosynthesis, and has been identified in higher fungi and several archaea and one thermophilic species of bacteria, Thermus thermophilus. HACN catalyses the hydration of cis-homoaconitate to (2R,3S)-homoisocitrate, but the HACN-catalysed dehydration of (R)-homocitrate to cis-homoaconitate has not been observed in vitro. We have synthesized the substrates and putative substrates for this enzyme, and in the present study report the first steady-state kinetic data for recombinant HACN from T. thermophilus using a (2R,3S)-homoisocitrate dehydrogenase-coupled assay. We have also examined the products of the reaction using HPLC. We do not observe HACN-catalysed 'homocitrate dehydratase' activity; however, we have observed that ACN can catalyse the dehydration of (R)-homocitrate to cis-homoaconitate, but HACN is required for subsequent conversion of cis-homoaconitate into homoisocitrate. This suggests that the in vivo process for conversion of homocitrate into homoisocitrate requires two enzymes, in simile with the propionate utilization pathway from Escherichia coli. Surprisingly, HACN does not show any activity when cis-aconitate is substituted for the substrate, even though other enzymes from the alpha-aminoadipate pathway can accept analogous tricarboxylic acid-cycle substrates. The enzyme shows no apparent feedback inhibition by L-lysine. 相似文献
994.
CCAAT/enhancer-binding protein homologous protein (CHOP) regulates osteoblast differentiation 总被引:4,自引:0,他引:4 下载免费PDF全文
995.
1. Parkinson's disease (PD) is considered to be an aging-related neurodegeneration of catecholamine (CA) systems [typically A9 dopamine (DA) neurons in the substantia nigra and A6 noradrenaline (NA) neurons in the locus coeruleus]. The main symptom is movement disorder caused by a DA deficiency at the nerve terminals of fibers that project from the substantia nigra to the striatum. Most PD is sporadic (sPD) without any hereditary history. sPD is speculated to be caused by some exogenous or endogenous substances that are neurotoxic toward CA neurons, which toxicity leads to mitochondrial dysfunction and subsequent oxidative stress resulting in the programmed cell death (apoptosis or autophagy) of DA neurons. 2. Recent studies on the causative genes of rare familial PD (fPD) cases, such as alpha-synuclein and parkin, suggest that dysfunction of the ubiquitin-proteasome system (UPS) and the resultant accumulation of misfolded proteins and endoplasmic reticulum stress may cause the death of DA neurons. 3. Activated microglia, which accompany an inflammatory process, are present in the nigro-striatum of the PD brain; and they produce protective or toxic substances, such as cytokines, neurotrophins, and reactive oxygen or nitrogen species. These activated microglia may be neuroprotective at first in the initial stage, and later may become neurotoxic owing to toxic change to promote the progression toward the death of CA neurons.4. All of these accumulating evidences on sPD and fPD points to a hypothesis that multiple primary causes of PD may be ultimately linked to a final common signal-transduction pathway leading to programmed cell death, i.e., apoptosis or autophagy, of the CA neurons. 相似文献
996.
Moderate severity heart failure does not involve a downregulation of myocardial fatty acid oxidation
Chandler MP Kerner J Huang H Vazquez E Reszko A Martini WZ Hoppel CL Imai M Rastogi S Sabbah HN Stanley WC 《American journal of physiology. Heart and circulatory physiology》2004,287(4):H1538-H1543
Recent human and animal studies have demonstrated that in severe end-stage heart failure (HF), the cardiac muscle switches to a more fetal metabolic phenotype, characterized by downregulation of free fatty acid (FFA) oxidation and an enhancement of glucose oxidation. The goal of this study was to examine myocardial substrate metabolism in a model of moderate coronary microembolization-induced HF. We hypothesized that during well-compensated HF, FFA oxidation would predominate as opposed to a more fetal metabolic phenotype of greater glucose oxidation. Cardiac substrate uptake and oxidation were measured in normal dogs (n = 8) and in dogs with microembolization-induced HF (n = 18, ejection fraction = 28%) by infusing three isotopic tracers ([9,10-(3)H]oleate, [U-(14)C]glucose, and [1-(13)C]lactate) in anesthetized open-chest animals. There were no differences in myocardial substrate metabolism between the two groups. The total activity of pyruvate dehydrogenase, the key enzyme regulating myocardial pyruvate oxidation (and hence glucose and lactate oxidation) was not affected by HF. We did not observe any difference in the activity of carnitine palmitoyl transferase I (CPT-I) and its sensitivity to inhibition by malonyl-CoA between groups; however, malonyl-CoA content was decreased by 22% with HF, suggesting less in vivo inhibition of CPT-I activity. The differences in malonyl-CoA content cannot be explained by changes in the Michaelis-Menten constant and maximal velocity for malonyl-CoA decarboxylase because neither were affected by HF. These results support the concept that there is no decrease in fatty acid oxidation during compensated HF and that the downregulation of fatty acid oxidation enzymes and the switch to carbohydrate oxidation observed in end-stage HF is only a late-stage phenomenon. 相似文献
997.
Fujii N Nozawa T Igawa A Kato B Igarashi N Nonomura M Asanoi H Tazawa S Inoue M Inoue H 《American journal of physiology. Heart and circulatory physiology》2004,287(2):H760-H766
Abnormalities in energy metabolism may play an important role in the development of hypertensive heart failure. However, the transition from compensated hypertrophy to heart failure is not fully understood in terms of energy metabolism. In Dahl salt-sensitive (DS) and salt-resistant (DR) rats, myocardial fatty acid and glucose uptake values were determined using (131)I- or (125)I-labeled 9-methylpentadecanoic acid ((131)I- or (125)I-9MPA), and [(14)C]deoxyglucose ([(14)C]DG), fatty acid beta-oxidation was identified using thin-layer chromatography, and insulin-stimulated glucose-uptake was observed using a euglycemic hyperinsulinemic glucose clamp. Six-week-old rats were fed a diet that contained 8% NaCl, which resulted in development of compensated hypertrophy in DS rats at 12 wk of age and ultimately led to heart failure by 18 wk of age. Uptake of [(14)C]DG increased markedly with age in the DS rats, whereas (131)I-9MPA uptake was marginally but significantly increased only in animals aged 12 wk. The ratio of (125)I-9MPA beta-oxidation metabolites to total uptake in the DS rats was significantly lower (P < 0.05) at 12 (37%) and 18 (34%) wk compared with at 6 (45%) wk. Insulin increased [(14)C]DG uptake more than twofold in the DS rats at 6 wk, although this increase was markedly attenuated at 12 and 18 wk (11 and 8%, respectively). Our data suggest that in a hypertrophied heart before heart failure, fatty acid oxidation is impaired and the capacity to increase glucose uptake during insulin stimulation is markedly reduced. These changes in both glucose and fatty acid metabolism that occur in association with myocardial hypertrophy may have a pathogenic role in the subsequent development of heart failure. 相似文献
998.
This paper presents a model which is based on biological research using the movable finite automata (MFA) on a self-assembly of T4 phage, and exhibits the results of artificial life simulation. In the previous work, Thompson and Goel [Artificial Life, Addison Weley, 1989, pp. 317-340; Biosystems 18 (1985) 23; J. Theor. Biol. 131 (1988) 351] presented the movable finite automata (MFA) which has a capability of moving on finite automata, and simulated on a computer. They were represented individual rectangular boxes, however, the results of simulation was different from real T4 phage. We propose the sphere model as a protein structure, and simulate the self-assembly of the entire structure of the T4 phage on a computer. 相似文献
999.
Effects on RNAi of the tight structure, sequence and position of the targeted region 总被引:34,自引:3,他引:31
RNA interference (RNAi) is a gene-silencing phenomenon that involves the double-stranded RNA-mediated cleavage of mRNA, and small interfering RNAs (siRNAs) can cause RNAi in mammalian cells. There have been many attempts to clarify the mechanism of RNAi, but information about the relationship between the sequence and structure, in particular, a tight structure, of the target RNA and the activities of siRNAs are limited. In the present study, we examined this relationship by introducing the TAR element, which adopts a very stable secondary structure, at different positions within target RNAs. Our results suggested that the activities of siRNAs were affected by the tight stem–loop structure of TAR. In contrast, the position of the target within the mRNA, the binding of the Tat protein to the TAR, and the location of the target within a translated or a noncoding region had only marginal effects on RNAi. When the target sequence was placed in two different orientations, only one orientation had a significant effect on the activities of siRNA, demonstrating that the presence of certain nucleotides at some specific positions was favorable for RNAi. Systematic analysis of 47 different sites within 47 plasmids under identical conditions indicated that it is the target sequence itself, rather than its location, that is the major determinant of siRNA activity. 相似文献
1000.